InBio Attending EAACI 2022 Hybrid Congress
InBio has completed a study comparing the allergen content of early introduction food (EIF) brands.
InBio Attending WAO-BSACI 2022
InBio is looking forward to attending its second big conference of the year, the World Allergy Organization (WAO) and British Society for Allergy & Clinical Immunology (BSACI) joint conference, in the spectacular city of Edinburgh.
InBio Attending AAAAI Annual Meeting 2022
InBio is excited to kick-off the year by attending our first big conference, the American Academy of Allergy, Asthma and Immunology Annual Meeting, starting February 26th.
CRISPR Cat Webinar
Indoor Biotechnologies is applying CRISPR gene editing to delete Fel d 1 from cat cells, an approach to creating a hypoallergenic cat.
SARS-CoV-2 Proteins and Simple T Cell Test Webinar
Indoor Biotechnologies has a suite of SARS-CoV-2 proteins in various expression systems, as well as a rapid whole blood T cell test in development.
Environmental Testing Suite and Viral Testing Webinar
Indoor Biotechnologies has recently expanded facilities and commissioned a new and improved Environmental Testing Suite (ETS) in Cardiff, Wales.
Molecular Approach to Allergy Diagnostics Webinar
Indoor Biotechnologies has designed and created a comprehensive portfolio of allergen components for diagnostic use, including dust mite, animal, food, mold, pollen, cockroach, venom and other allergens.
Allergen Variability in Early Introduction Foods Webinar
InBio has completed a study comparing the allergen content of early introduction food (EIF) brands.